According to the same source, private insurance claim lines for Lyme disease diagnosis increased by 357 percent in rural areas and by 65 percent in urban areas in 2021 compared to the previous ten years. Despite the fact that Lyme disease can be treated with medications, some Lyme patients subsequently experience illnesses with chronic symptoms like exhaustion, joint and muscle pain, and cognitive problems. Post-treatment Lyme disease syndrome, often known as persistent Lyme disease, has been connected to these illnesses.

The serological test, which is highly preferred among all tests since it measures antibodies in the late stages of the illness when both the nucleic acid test and the polymerase chain reaction test are negative, is predicted to dominate the Lyme Disease Treatment Market. When assessing Lyme illness, these tests are highly helpful. To diagnose infectious infections, serological assays using the ELISA, agglutination, precipitation, and western blot techniques are utilised. Additionally, the targeted patient pool chooses this test, which supports the Lyme disease diagnostic market due to the rising prevalence of Lyme illness and growing need for diagnostic tests.

Read More- https://cmi-latestreportorientedblogs.blogspot.com/2023/04/lyme-disease-treatment-market-share.html